Enhanced patient recovery with early extensive surgical deb-ridement in Fournier's Gangrene: evaluation of perioperative outcomes in a multicentric experience

Authors

Objective: Fournier's gangrene (FG) is a rare, life-threatening necrotizing fasciitis primarily affecting the perineal, genital, and perianal regions. This rapidly progressing bacterial infection predominantly affects middleaged and elderly men. This multicenter study aims to describe the management in a wide cohort of Fournier's gangrene cases that presented to three tertiary centers with early extensive surgical debridement.
Materials and Methods: We retrospectively collect data from patients with FG who were referred to the Urology Clinic of the Department of Medicine and Surgery (Perugia), the Urological Andrological Surgery and Minimally Invasive Techniques Unit (Terni) of the University of Perugia, and the Urology Unit of the Surgery Department of the Macerata Civic Hospital between January 2019 and March 2024 for onset of classic signs and symptoms of FG. Extensive surgical debridement was immediately performed under general anesthesia to reach normochromic and vascularized tissue in wide and depth extension, assuring vital and healthy margins. For all patients, intravenous daptomycin plus piperacillin/tazobactam were administered.
Results: 28 male patients with FG underwent early surgical debridement. In two cases, orchidectomy and partial penectomy were required during surgical debridement due to extensive necrosis. Colon diversion and urinary diversion were not necessary for any of the patients. 32.1% complications were recorded according to the Clavien Dindo classification; 6 patients died in the perioperative. Excluding death data, the average duration of antibiotic therapy was 22.0±9.1 days, and the average length of stay was 17.6±11.8 days.
Conclusions: Fournier's gangrene has high mortality rates. It requires timely surgical debridement and antibiotic therapy to achieve positive outcomes. This study shows that a primary extensive debridement can help reduce the need for further intervention and shorten the hospital stay.

Singh A, Ahmed K, Aydin A, et al. Fournier’s gangrene. A clinical review. Arch Ital Urol Androl. 2016; 88:157.
Paladini A, Cochetti G, Tancredi A, et al. Management of Fournier’s gangrene during the Covid-19 pandemic era: make a virtue out of necessity. Basic Clin Androl. 2022; 32:12.
Sorensen MD, Krieger JN. Fournier’s Gangrene: Epidemiology and Outcomes in the General US Population. Urol Int. 2016; 97:249-59.
Chernyadyev SA, Ufimtseva MA, Vishnevskaya IF, et al. Fournier’s Gangrene: Literature Review and Clinical Cases. Urol Int. 2018;101:91-7.
Ellegård L, Prytz M. Fournier’s gangrene under SGLT-2 inhibitor therapy: A literature review and case report. Int J Surg Case Rep. 2020; 77:692-4.
Del Zingaro M, Boni A, De Vermandois JAR, et al. Fournier’s gangrene and intravenous drug abuse: an unusual case report and review of the literature. Open Medicine. 2019; 14:694-710.
Del Zingaro M, Boni A, Paladini A, et al. Fournier’s gangrene secondary to locally advanced prostate cancer: case report and review of the Literature. G Chir. 2019; 40:481-96.
Molla YD, Assefa MA, Abraha AY. Fournier’s gangrene with retroperitoneal extension, a case report. Int J Surg Case Rep. 2023;105:107984.
Ioannidis O, Kitsikosta L, Tatsis D, et al. Fournier’s gangrene: lessons learned from multimodal and multidisciplinary management of perineal necrotizing fasciitis. Front Surg. 2017; 4:36.
Auerbach J, Bornstein K, Ramzy M, et al. Fournier gangrene in the emergency department: diagnostic dilemmas, treatments and current perspectives. Open Access Emerg Med. 2020; 12:353-364.
Singh A, Ahmed K, Aydin A, et al. Fournier’s gangrene. A clinical review. Arch Ital Urol Androl. 2016; 88:157.
Wong C-H, Khin L-W, Heng K-S, et al. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections*. Crit Care Med. 2004; 32:1535-41.
Laor E, Palmer LS, Tolia BM, et al. Outcome prediction in patients with Fournier’s gangrene. J Urol. 1995; 154:89-92.
Czymek R, Frank P, Limmer S, et al. Fournier’s gangrene: is the female gender a risk factor? Langenbecks Arch Surg. 2010; 395:173-80.
Kincius M, Telksnys T, Trumbeckas D, et al. Evaluation of LRINEC scale feasibility for predicting outcomes of Fournier gangrene. Surg Infect (Larchmt). 2016; 17:448-53.
Wang T-L, Hung C-R. Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med. 2004; 44:222-8.
Lin T-Y, Cheng I-H, Ou C-H, et al. Incorporating simplified Fournier’s gangrene severity index with early surgical intervention can maximize survival in high-risk Fournier’s gangrene patients. Int J Urol. 2019; 26:737-43.
Raizandha MA, Hidayatullah F, Kloping YP, et al. The role of hyperbaric oxygen therapy in Fournier’s gangrene: A systematic review and meta-analysis of observational studies. Int Braz J Urol. 2022; 48:771-81.
Assenza M, Cozza V, Sacco E, et al. VAC (vacuum assisted closure) treatment in Fournier’s gangrene: personal experience and literature review. Clin Ter. 2011; 162:e1-5.
Zhang R, Zhang Y, Hou L, Yan C. Vacuum-assisted closure versus conventional dressing in necrotizing fasciitis: a systematic review and meta-analysis. J Orthop Surg Res. 2023; 18:85.
Agarwal P, Kukrele R, Sharma D. Vacuum assisted closure (VAC)/negative pressure wound therapy (NPWT) for difficult wounds: A review. J Clin Orthop Trauma. 2019; 10:845-8.
Yilmazlar T, Isik O, Ozturk E, et al. Fournier’s gangrene: review of 120 patients and predictors of mortality. Ulus Travma Acil Cerrahi Derg. 2014; 20:333-7.
Sparenborg JD, Brems JA, Wood AM, et al. Fournier’s gangrene: a modern analysis of predictors of outcomes. Transl Androl Urol. 2019; 8:374-8.
Al-Kohlany K, Baker K, Ahmed F, et al. Treatment outcome of Fournier’s gangrene and its associated factors: A retrospective study. Arch Ital Urol Androl. 2023; 95:11318.
Ghabisha S, Ahmed F, Al-wageeh S, et al. Prognostic determinants and treatment outcomes of Fournier’s gangrene treatment in a resource-limited setting: A retrospective study. Arch Ital Urol Androl. 2023; 95:11450.
Wirjopranoto S, Affandi MR, Ashari FY, et al. Evaluating prognostic indicators for in-hospital mortality in Fournier’s gangrene: a 7-year study in a tertiary hospital. Arch Ital Urol Androl. 2024;96:12387.
Carroll PR, Cattolica E V, Turzan CW, McAninch JW. Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction. West J Med. 1986; 144:174-8.
Bowen D, Juliebø-Jones P, Somani BK. Global outcomes and lessons learned in the management of Fournier’s gangrene from highvolume centres: findings from a literature review over the last two decades. World J Urol. 2022;40:2399-410.

How to Cite

Cochetti, G., Paladini, A., Lepri, L., Vitale, A., La Mura, R., Russo, M., Mangione, P., Mearini, M., Fabiani, A., Iacobone, E., Servi, L., Mearini, E., & Del Zingaro, M. (2025). Enhanced patient recovery with early extensive surgical deb-ridement in Fournier’s Gangrene: evaluation of perioperative outcomes in a multicentric experience. Archivio Italiano Di Urologia E Andrologia. https://doi.org/10.4081/aiua.2025.13207